We are thrilled to announce the publication of a revolutionary new article by Dr. Thalberg, titled “New theory to explain the effect of lactose fines on the performance of adhesive mixtures for inhalation.” This pioneering research, now available in the International Journal of Pharmaceutics, presents a novel theory on how dry powders for inhalation actually works.
Dr. Thalberg’s work sheds new light on the role of lactose fines in enhancing the performance of adhesive mixtures, potentially revolutionizing the design and control of inhalation therapies. This significant advancement in pharmaceutical science promises to improve the delivery of medication for patients with respiratory conditions.
Read the full article here and join us in celebrating this remarkable achievement in the field of inhalation therapy.